NLC, founded in 2015, is a new breed of healthtech venture builder that has been awarded B-Corp certification in 2020. By using entrepreneurship at scale, they bring together the best tech, the best people, and the best capital to build life-changing healthtech ventures.
NLC estimates that 95% of science-based healthtech inventions never reach the patient, while bringing them to the market would be life-changing for many. To advance health, accessible for everyone, NLC gives investors unique access to early-stage research developments. It’s a rare opportunity to shape the future of medical technology.
Bioverge and the Bioverge logo are the property of Bioverge, Inc. All other product names, logos, and brands are property of their respective owners.